Alastair Stuart McEwan
Corporate Officer/Principal at The Institute of Chartered Accountants of Scotland
Profile
Alastair Stuart McEwan is a Member of The Institute of Chartered Accountants of Scotland.
He previously held positions such as Chief Executive Officer at IT&E International Group, Inc., Chairman at Cornerstone BioPharma, Inc., and Group Executive Director at Inveresk Research Group, Inc. He also served as a Director at Critical Therapeutics, Inc., Averion, Inc., and Averion International Corp., and as Vice President at Charles River Laboratories International, Inc. He was a Partner at Maclay Murray & Spens LLP from 2004 to 2011.
McEwan earned an undergraduate degree from The University of Edinburgh.
Currently, he holds a position as Chief Operating Officer, EVP & IR Contact at Veloxis Pharmaceuticals A.
Alastair Stuart McEwan active positions
Companies | Position | Start |
---|---|---|
The Institute of Chartered Accountants of Scotland
The Institute of Chartered Accountants of Scotland Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright. | Corporate Officer/Principal | - |
Former positions of Alastair Stuart McEwan
Companies | Position | End |
---|---|---|
VELOXIS PHARMACEUTICALS A/S | Chief Operating Officer | 2017-09-19 |
Maclay Murray & Spens LLP
Maclay Murray & Spens LLP Miscellaneous Commercial ServicesCommercial Services Maclay Murray & Spens LLP provides legal services. The firm provides services to banking & finance, construction & engineering, regulations, information technology, intellectual property, employment, litigation, property, and tax sectors. It offices are located in Aberdeen, Edinburgh, London, and Brussels. The company was founded in 1871 and is headquartered in Glasgow, UK. | Corporate Officer/Principal | 2011-05-30 |
Averion, Inc. | Director/Board Member | 2009-07-06 |
CORNERSTONE THERAPEUTICS, INC. | Chairman | 2009-07-09 |
IT&E International Group, Inc. | President | 2006-07-30 |
Training of Alastair Stuart McEwan
The University of Edinburgh | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Commercial Services |
Private companies | 10 |
---|---|
Inveresk Research Group, Inc.
Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Inveresk Research Group, Inc. provides drug development services to companies in the pharmaceutical and biotechnology industries. The company offers pre-clinical safety & pharmacology evaluation, laboratory sciences, and clinical development services. Inveresk Research Group was founded in 1999 and is headquartered in Cary, NC. | Commercial Services |
IT&E International Group, Inc. | Finance |
Critical Therapeutics, Inc. | Health Technology |
Cornerstone BioPharma, Inc.
Cornerstone BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone BioPharma, Inc. develops and commercializes biopharmaceutical products for respiratory disorders. Its products include AlleRx, Balacet, Deconsal, and Spectracef. The company was founded in March 2004 by Craig A. Collard, Chenyqua Baldwin, and Steven Lutz and is headquartered in Cary, NC | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Maclay Murray & Spens LLP
Maclay Murray & Spens LLP Miscellaneous Commercial ServicesCommercial Services Maclay Murray & Spens LLP provides legal services. The firm provides services to banking & finance, construction & engineering, regulations, information technology, intellectual property, employment, litigation, property, and tax sectors. It offices are located in Aberdeen, Edinburgh, London, and Brussels. The company was founded in 1871 and is headquartered in Glasgow, UK. | Commercial Services |
Averion, Inc. | Commercial Services |
Averion International Corp.
Averion International Corp. Miscellaneous Commercial ServicesCommercial Services Averion International Corp. provides clinical research services. It serves for pharmaceutical, biotechnology and medical device industries. The company mainly focuses on oncology, nephrology, dermatology and medical devices. The company was founded on April 22, 2002 and is headquartered in Southborough, MA. | Commercial Services |
The Institute of Chartered Accountants of Scotland
The Institute of Chartered Accountants of Scotland Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants of Scotland operates as a professional membership organization. The non-profit company is based in Edinburgh, UK. The British company was founded by Janice Margaret Brown and Sundeep Bahanda. The CEO is Bruce Cartwright. | Commercial Services |
Cornerstone Therapeutics, Inc.
Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
- Stock Market
- Insiders
- Alastair Stuart McEwan